Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)
1 other identifier
interventional
96
1 country
6
Brief Summary
Children with disabilities often access rehabilitation services to improve their abilities to participate in everyday activities. Goal-directed therapy is considered an important therapeutic strategy to achieve outcomes that are meaningful to families. Not a lot is known about the effects of goal setting on rehabilitation outcomes. Strategies to help children participate in the goal-setting process are rarely used in clinical practice. The aim of this project is to test the effects of a child-focussed goal setting approach, Enhancing Child Engagement in Goal Setting (ENGAGE), on therapy outcomes. Service use and the cost vs. benefits of the ENGAGE approach compared to usual practice will also be examined. Children with neurodevelopmental disabilities aged 5-12 years old (n=96) who access paediatric rehabilitation services at six rehabilitation sites will participate. Therapists (n=24) at participating sites in Alberta, Canada will be randomized into 1) the ENGAGE intervention group or 2) the usual therapy practice control group. Children will participate in the ENGAGE approach to goal setting or usual practice based on the allocation of their therapist. This study will determine if the ENGAGE approach to goal setting affects child goal performance, satisfaction with goal performance, functional abilities, participation, and parent and child quality of life. The investigators will also evaluate differences in parent and child quality of life in relation to parent costs (e.g., absenteeism, presenteeism, travel costs) and compare amount of therapy time between the two groups to see which approach is more cost-effective and efficient. After the study, children, parents and therapists will be asked to discuss aspects that influenced effective implementation of the ENGAGE approach. This study could provide evidence to improve meaningful child and family outcomes in paediatric rehabilitation and improve efficiency of paediatric rehabilitation services.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 14, 2019
CompletedFirst Posted
Study publicly available on registry
September 19, 2019
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
January 6, 2026
December 1, 2025
4.3 years
August 14, 2019
December 31, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Goal performance and satisfaction will be measured using the Canadian Occupational Performance Measure (COPM).
Change in the COPM will be examined between baseline (pre-treatment) and post-treatment (within 10 days of completing therapy), and post-treatment (within 10 days of completing therapy) and 3-months post-treatment. The COPM is an interview style measure in which a child is asked by an assessor to identify goal areas and then rate their current level on a 1 to 10 scale as far as importance, satisfaction and performance. A higher score represents a more favorable outcome.
1) baseline (pre-treatment), 2) post-treatment (within 10 days of completing therapy), and 3) at 3-months post-treatment
Secondary Outcomes (7)
Child engagement in therapy will be measured using the Pediatric Rehabilitation Intervention Measure of Engagement (PRIME-SP).
1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment
Perceived confidence will be measured using the Belief in Goal Self-Competence Scale [BiGSS].
1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment
Goal related performance will be measured using the Goal Attainment Scaling (GAS).
1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment
Participation for young children will be measured using the Participation and Environment Measure for Children & Youth (PEM-CY).
1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment
Quality of life for children will be measured using the KIDSCREEN-27.
1) baseline (pre-treatment), 2) post-treatment (within 10 days), and 3) at 3-months post-treatment
- +2 more secondary outcomes
Study Arms (2)
ENGAGE approach (child-oriented goal-setting)
EXPERIMENTALTherapists will receive training on our principles-based goal setting approach and strategies in the goal setting toolbox. Training will include an overview of tools and strategies including the Perceived Efficacy and Goal Setting Tool (PEGS) and the Pediatric Activity Card Sort (PACS). In addition, we will provide training on Goal Attainment Scaling and administration of the Canadian Occupational Performance Measure (COPM). We will introduce simple strategies to assist children in identifying goals and to ensure ongoing focus on goals using principles of motivational interviewing, strategies to assess and nurture perceived competence (self-efficacy), and child-friendly feedback strategies on goal-related performance.
Usual care
NO INTERVENTIONThe control group will comprise of usual care.
Interventions
See description of experimental arm.
Eligibility Criteria
You may qualify if:
- are between the ages of 5-12 years
- are able to engage in the goal-setting process (determined by therapists)
- are referred to PT and/or OT for a period of direct treatment
- speak English.
- Children will be excluded from the trial if:
- the parent or guardian who attends therapy does not speak English
- the child has a diagnosis that suggests developmental regression
- the child has uncontrolled seizures (i.e., seizure within the past 2 months).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Albertalead
- Alberta Health servicescollaborator
Study Sites (6)
Renfrew Educational Services
Calgary, Alberta, T2E 6S5, Canada
Society for Treatment of Autism
Calgary, Alberta, T2J 0E8, Canada
Children's Rehabilitation Services, Alberta Health Services
Camrose, Alberta, Canada
Centre for Autism Services Alberta
Edmonton, Alberta, T6E 5H5, Canada
Children's Rehabilitation Services, Alberta Health Services
Grande Prairie, Alberta, Canada
Children's Rehabilitation Services, Alberta Health Services
Red Deer, Alberta, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lesley Pritchard-Wiart, PhD
University of Alberta, Faculty of Rehabilitation Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Trained assessors, blinded to group allocation, will complete the measures with families. Family members will be blinded to all initial responses on the measures.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 14, 2019
First Posted
September 19, 2019
Study Start
March 1, 2022
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
January 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share